Cargando…

Single-cell genomics identifies immune response to neoadjuvant chemoradiotherapy

Detalles Bibliográficos
Autores principales:	Sinha, Uttam K., Kast, W. Martin, Lin, De-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718959/ https://www.ncbi.nlm.nih.gov/pubmed/36463779 http://dx.doi.org/10.1016/j.ebiom.2022.104389

Ejemplares similares

Non-invasively predicting response to neoadjuvant chemotherapy in gastric cancer via deep learning radiomics
por: Fang, Mengjie, et al.
Publicado: (2022)

Impacts of neoadjuvant chemoradiotherapy on the immune landscape of esophageal squamous cell carcinoma
por: Wen, Jing, et al.
Publicado: (2022)

Large-scale genomic analyses reveal alterations and mechanisms underlying clonal evolution and immune evasion in esophageal cancer
por: Lin, De-Chen
Publicado: (2023)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2018)

Genomic and Transcriptomic Characterisation of Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Toomey, Sinead, et al.
Publicado: (2020)

Dissecting the human microbiome with single-cell genomics
por: Tolonen, Andrew C., et al.
Publicado: (2017)

Addendum: Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma
por: Chen, Yongshun, et al.
Publicado: (2022)

Single cell genomics of bacterial pathogens: outlook for infectious disease research
por: McLean, Jeffrey S, et al.
Publicado: (2014)

Immune Response and Immune Checkpoint Molecules in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy: A Review
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Coronavirus is the trigger, but the immune response is deadly
por: Cron, Randy Q
Publicado: (2020)

The truth lies somewhere in the middle: the cells responsible for liver tissue maintenance finally identified
por: Itoh, Tohru
Publicado: (2021)

Accelerating genomics-based surveillance for COVID-19 response in Africa
por: Tessema, Sofonias K, et al.
Publicado: (2020)

Antifungal immune responses: emerging host–pathogen interactions and translational implications
por: Kumar, Vinod, et al.
Publicado: (2018)

Using genomics to improve preparedness and response of future epidemics or pandemics in Africa
por: Chaguza, Chrispin, et al.
Publicado: (2020)

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma
por: Goedegebuure, R.S.A., et al.
Publicado: (2021)

The emerging roles of exosomes in the modulation of immune responses in cancer
por: Kurywchak, Paul, et al.
Publicado: (2018)

COVID-19 infection: mitohormetic concept of immune response
por: Gebicki, Jerzy, et al.
Publicado: (2020)

Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
por: Huang, Ren-Wen, et al.
Publicado: (2014)

Master manipulators: how herpesviruses alter immune responses to RSV
por: Gurczynski, Stephen J., et al.
Publicado: (2020)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

CT radiomics identifying non‐responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer
por: Zhang, Zinan, et al.
Publicado: (2022)

Novel Plasmodium vivax genomes from Brazil identify targets for studies on drug resistance, transmission networks, and parasite evolution
por: Da Silva, Gustavo, et al.
Publicado: (2023)

Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
por: Guo, Su-ping, et al.
Publicado: (2021)

An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma
por: Qian, Liwen, et al.
Publicado: (2022)

MERS-CoV: the intermediate host identified?
por: de Wit, Emmie, et al.
Publicado: (2013)

Predictive Factors for Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
por: Zhang, Qi, et al.
Publicado: (2021)

Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer
por: Filitto, Giuseppe, et al.
Publicado: (2022)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
por: Lin, Huaqin, et al.
Publicado: (2021)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy and Larynx-Preserving Surgery for Cervical Esophageal Cancer
por: Dai, Kun-Yao, et al.
Publicado: (2020)

Heterogeneity and cell fate flux in single human pancreatic islet cells
por: Ng, Natasha H. J., et al.
Publicado: (2018)

Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer()()
por: Smithson, Mary, et al.
Publicado: (2022)

Restaging rectal cancer following neoadjuvant chemoradiotherapy
por: Cuicchi, Dajana, et al.
Publicado: (2023)

Gastric Perforation in a Patient Receiving Neoadjuvant Chemoradiotherapy
por: Chen, Hui, et al.
Publicado: (2015)

Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study
por: Ólafsdóttir, Halla Sif, et al.
Publicado: (2023)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta‐analysis
por: Fan, Mengying, et al.
Publicado: (2015)

AusTrakka: Fast-tracking nationalized genomics surveillance in response to the COVID-19 pandemic
por: Hoang, Tuyet, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_khaic8mbjpb7b52uoshqntcg20